Cyrusone Stock Price, News & Analysis
Company Description
Cyrusone (NASDAQ: CONE) is a publicly traded reit—specialty company in the Real Estate sector. The company has a market capitalization of $11.9B.
CONE stock has gained 32.9% over the past year.
This page provides a comprehensive overview of CONE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cyrusone (CONE) stock. Over the past 12 months, the stock has gained 32.9%. At a market capitalization of $11.9B, CONE is classified as a large-cap stock with approximately 129.6M shares outstanding.
Latest News
Cyrusone has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include management, acquisition, earnings. View all CONE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CONE Company Profile & Sector Positioning
Cyrusone (CONE) operates in the REIT—Specialty industry within the broader Real Estate sector and is listed on the NASDAQ.
Investors comparing CONE often look at related companies in the same sector, including Host Hotels (HST), Camden Ppty Tr (CPT), Lamar Advertising Co (LAMR), Omega Healthcare (OHI), and Healthpeak Properties Inc (DOC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CONE's relative position within its industry.